glp 1 sacramento GLP‑1 Weight Loss The Connection Between GLP-1 Medications

[1] [2] Secondly, they suppress the inappropriate secretion of glucagon from pancreatic alpha cells, which otherwise raises blood glucose

Any potential advantage must be weighed against the well characterised adverse event profile of GLP-1 receptor agonistsincluding gastrointestinal intolerance, gallbladder disease, acute pancreatitis, and other adverse eventswithin a shared, patient centred decision making process that balances individual risk against potential additive gains.1 The observed epidemiological patterns in our study are highly consistent with the known pharmacology and neurobiological mechanisms of GLP-1 receptor agonists

But what makes Oprahs story so powerful is what happened next

Additionally, there were no significant differences in diabetes duration, fasting glucose levels, antidiabetic drug use (including insulin), or comorbidities between the GLP-1 RA group and the DM control group

Therapeutic effects of semaglutide on nonalcoholic fatty liver disease with type 2 diabetes mellitus and obesity: an open-label controlled trial

GLP-1 RAs exhibit anti-inflammatory properties through inhibition of NF-B pathways and macrophage infiltration in adipose tissue